Bimin Shi Selected Research

Insulin Glargine (Lantus)

6/2018	Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial.
1/2018	Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bimin Shi Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2014
5	Insulin Resistance 01/2022 - 10/2015
4	Body Weight (Weight, Body) 11/2023 - 01/2014
3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
3	Obesity 01/2020 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 09/2016
2	Carotid Artery Diseases 06/2022 - 01/2022
2	Inflammation (Inflammations) 09/2019 - 01/2018
2	Overweight 01/2019 - 06/2018
1	Diarrhea 11/2023
1	Nausea 11/2023
1	Vomiting 11/2023
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	Hypertrophy 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Heart Failure 06/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fatty Liver 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Albuminuria 03/2021
1	Hypotension (Low Blood Pressure) 03/2021
1	Weight Loss (Weight Reduction) 02/2021
1	Hypothyroidism 01/2021
1	Hyperthyroidism 01/2021
1	Ulcer 01/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Neuralgia (Stump Neuralgia) 12/2020
1	Pain (Aches) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2019
1	Peptic Ulcer (Peptic Ulcers) 09/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Weight Gain 01/2019
1	Thyroid Nodule (Nodule, Thyroid) 06/2018
1	Neoplasms (Cancer) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Glucose Metabolism Disorders 01/2018
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2023 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
3	Metformin (Glucophage)FDA LinkGeneric 11/2023 - 01/2018
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023 - 01/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	CreatinineIBA 03/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2018
2	LipidsIBA 01/2019 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 06/2018 - 01/2018
1	LigandsIBA 04/2024
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2023
1	mazdutideIBA 11/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023
1	dulaglutideIBA 11/2023
1	CytokinesIBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	Sodium-Glucose Transport ProteinsIBA 06/2023
1	dapagliflozinIBA 06/2023
1	empagliflozinIBA 01/2023
1	Beclin-1IBA 05/2022
1	TenascinIBA 01/2022
1	growth arrest-specific protein 6IBA 01/2022
1	alarinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	NAD (NADH)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	C-PeptideIBA 03/2021
1	CholesterolIBA 02/2021
1	ON101IBA 01/2021
1	GlucokinaseIBA 01/2021
1	Cystatin CIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	Galectins (Galectin)IBA 01/2020
1	CarbenoxoloneIBA 09/2019
1	Chemotactic FactorsIBA 01/2019
1	saxagliptin FDA Link 01/2019
1	AlbuminsIBA 01/2019
1	glimepiride (Amarel)FDA LinkGeneric 01/2019
1	Polidocanol (Laureth)FDA Link 06/2018
1	Ethanol (Ethyl Alcohol)IBA 06/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	Thyroid HormonesIBA 01/2018
1	NeuropeptidesIBA 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	AutoantibodiesIBA 09/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2015
1	Glycogen Synthase (Synthase I)IBA 10/2015
1	PalmitatesIBA 10/2015
1	p38 Mitogen-Activated Protein KinasesIBA 10/2015

Therapy/Procedure

2	Glycemic Control 03/2021 - 01/2014
2	Therapeutics 01/2019 - 01/2019
1	Sclerotherapy 06/2018
1	Cell Transplantation 01/2018